☆ 4.7 Letter

A New Variant of 16S rRNA Methylase, RmtD3, in a Clinical Isolate of Pseudomonas aeruginosa in Myanmar

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)

Journal

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Volume 62, Issue 1, Pages -

Publisher

AMER SOC MICROBIOLOGY

DOI: 10.1128/AAC.01806-17

Keywords

16S rRNA methylase; Myanmar; Pseudomonas aeruginosa; RmtD3; aminoglycoside resistance

Funding

Grants-in-Aid for Scientific Research [16K19133, 15H05280] Funding Source: KAKEN

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

A New Variant of 16S rRNA Methylase, RmtD3, in a Clinical Isolate of Pseudomonas aeruginosa in Myanmar

Journal

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Publisher

AMER SOC MICROBIOLOGY

Keywords

Categories

Funding

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

A New Variant of 16S rRNA Methylase, RmtD3, in a Clinical Isolate of Pseudomonas aeruginosa in Myanmar

Journal

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Publisher

AMER SOC MICROBIOLOGY

Keywords

Categories

Funding

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Export Citation

Share Paper